1. Home
  2. IOVA vs COHU Comparison

IOVA vs COHU Comparison

Compare IOVA & COHU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • COHU
  • Stock Information
  • Founded
  • IOVA 2007
  • COHU 1947
  • Country
  • IOVA United States
  • COHU United States
  • Employees
  • IOVA N/A
  • COHU N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • COHU Electrical Products
  • Sector
  • IOVA Health Care
  • COHU Industrials
  • Exchange
  • IOVA Nasdaq
  • COHU Nasdaq
  • Market Cap
  • IOVA 975.1M
  • COHU 885.9M
  • IPO Year
  • IOVA N/A
  • COHU N/A
  • Fundamental
  • Price
  • IOVA $2.38
  • COHU $21.18
  • Analyst Decision
  • IOVA Buy
  • COHU Buy
  • Analyst Count
  • IOVA 11
  • COHU 6
  • Target Price
  • IOVA $11.90
  • COHU $28.20
  • AVG Volume (30 Days)
  • IOVA 11.2M
  • COHU 373.8K
  • Earning Date
  • IOVA 11-06-2025
  • COHU 10-30-2025
  • Dividend Yield
  • IOVA N/A
  • COHU N/A
  • EPS Growth
  • IOVA N/A
  • COHU N/A
  • EPS
  • IOVA N/A
  • COHU N/A
  • Revenue
  • IOVA $241,525,000.00
  • COHU $393,941,000.00
  • Revenue This Year
  • IOVA $67.40
  • COHU $13.11
  • Revenue Next Year
  • IOVA $56.32
  • COHU $11.48
  • P/E Ratio
  • IOVA N/A
  • COHU N/A
  • Revenue Growth
  • IOVA 636.99
  • COHU N/A
  • 52 Week Low
  • IOVA $1.64
  • COHU $12.57
  • 52 Week High
  • IOVA $12.51
  • COHU $29.42
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 49.08
  • COHU 61.81
  • Support Level
  • IOVA $2.27
  • COHU $20.20
  • Resistance Level
  • IOVA $2.46
  • COHU $21.49
  • Average True Range (ATR)
  • IOVA 0.14
  • COHU 0.57
  • MACD
  • IOVA 0.00
  • COHU 0.12
  • Stochastic Oscillator
  • IOVA 49.09
  • COHU 87.40

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

Share on Social Networks: